Task: Answer the multiple-choice question.
Question: Which drug has a 4.838% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCC(=O)Nc1ccc(NC(=O)CSc2nnnn2-c2cccnc2)cc1C
b Cc1c(C=O)c2cc(OCc3ccccc3)ccc2n1C
c CCOc1ccc(C2SCC(=O)Nc3c2c(C)nn3C2CCOC(C)(C)C2)cc1
Answer: a. CCC(=O)Nc1ccc(NC(=O)CSc2nnnn2-c2cccnc2)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccc(NC(=O)CSc2nnnn2-c2cccnc2)cc1C
CCC(=O)Nc1ccc(NC(=O)CSc2nnnn2-c2cccnc2)cc1C
N-[2-methyl-4-[[2-(1-pyridin-3-yltetrazol-5-yl)sulfanylacetyl]amino]phenyl]propanamide